National Biodefense Science Board; Call for Nominees, 30832-30833 [2010-13177]
Download as PDF
<![CDATA[
sroberts on DSKD5P82C1PROD with NOTICES
30832
Federal Register / Vol. 75, No. 105 / Wednesday, June 2, 2010 / Notices
the date of publication in this Federal
Register:
FAX: 202–395–6974, Attn: Ms. Sharon
Mar, OMB Desk Officer for the Office of
Government Ethics;
E-mail: smar@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT: Mr.
Paul Ledvina at the Office of
Government Ethics; telephone: 202–
482–9247; TTY: 800–877–8339; FAX:
202–482–9237; E-mail:
paul.ledvina@oge.gov. An electronic
copy of the SF 278 is available in the
Forms Library section of OGE’s Web site
at https://www.usoge.gov. A paper copy
may also be obtained, without charge,
by contacting Mr. Ledvina.
SUPPLEMENTARY INFORMATION:
Title: Executive Branch Personnel
Public Financial Disclosure Report.
Form Number: SF 278.
OMB Control Number: 3209–0001.
Type of Information Collection:
Extension without change of a currently
approved collection.
Type of Review Request: Regular.
Respondents: Private citizen
Presidential nominees to executive
branch positions subject to Senate
confirmation; other private citizens who
are potential (incoming) Federal
employees whose positions are
designated for public financial
disclosure filing; those who file
termination financial disclosure reports
for such positions after their
Government service ends; and
Presidential and Vice-Presidential
candidates.
Estimated Annual Number of
Respondents: 1,300.
Estimated Time per Response: 3
hours.
Estimated Total Annual Burden:
3,900 hours.
Abstract: The SF 278 collects
information from certain officers and
high-level employees in the executive
branch for conflicts of interest review
and public disclosure. The form is also
completed by individuals who are
nominated by the President for highlevel executive branch positions
requiring Senate confirmation and new
entrants to other public reporting
positions in the executive branch. The
financial information collected relates
to: assets and income; transactions; gifts,
reimbursements and travel expenses;
liabilities; agreements or arrangements;
outside positions; and compensation
over $5,000 paid by a source—all
subject to various reporting thresholds
and exclusions. The information is
collected in accordance with section
102 of the Ethics Act, 5 U.S.C. app.
section 102, and OGE’s implementing
financial disclosure regulations at 5 CFR
part 2634.
VerDate Mar<15>2010
19:08 Jun 01, 2010
Jkt 220001
Request for Comments: OGE
published a first round notice of its
intent to request paperwork clearance
for the proposed unmodified SF 278
Executive Branch Personnel Public
Financial Disclosure Report on March
19, 2010 (see 75 FR 13287). OGE
received no responses to that notice.
Agency and public comment is again
invited specifically on the need for and
practical utility of this information
collection, the accuracy of OGE’s
burden estimate, the enhancement of
quality, utility and clarity of the
information collected, and the
minimization of burden (including the
use of information technology).
Comments received in response to this
notice will be summarized for, and may
be included with, the OGE request for
extension of OMB paperwork approval.
The comments will also become a
matter of public record.
Approved: May 26, 2010.
Robert I. Cusick,
Director, Office of Government Ethics.
[FR Doc. 2010–13187 Filed 6–1–10; 8:45 am]
BILLING CODE 6345–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Biodefense Science Board;
Call for Nominees
AGENCY: Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
SUMMARY: The Office of the Secretary is
accepting resumes or curricula vitae
from qualified individuals who wish to
be considered for membership on the
National Biodefense Science Board. Six
members have membership expiration
dates of December 31, 2010. Nominees
are being accepted in the following
categories: industry; academia, health
care consumers, and from State and
local governments and public health
agencies, emergency responders and
organizations representing other
appropriate stakeholders. Submit a
resume or curriculum vitae to
nbsb@hhs.gov by June 30, 2010.
FOR FURTHER INFORMATION,
CONTACT: CAPT Leigh A. Sawyer,
D.V.M., M.P.H., Executive Director,
National Biodefense Science Board,
Office of the Assistant Secretary for
Preparedness and Response, U.S.
Department of Health and Human
Services, 330 C Street, SW., Switzer
Building Room 5127, Washington, DC
20447; 202–205–3815; fax: 202–205–
8508; e-mail address:
leigh.sawyer@hhs.gov.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Pursuant
to section 319M of the Public Health
Service Act (42 U.S.C. 247d-7f) and
section 222 of the Public Health Service
Act (42 U.S.C. 217a), the Department of
Health and Human Services established
the National Biodefense Science Board.
The Board shall provide expert advice
and guidance to the Secretary on
scientific, technical, and other matters
of special interest to the Department of
Health and Human Services regarding
current and future chemical, biological,
nuclear, and radiological agents,
whether naturally occurring, accidental,
or deliberate. The Board may also
provide advice and guidance to the
Secretary on other matters related to
public health emergency preparedness
and response.
Discription of Duties: The Board shall
advise the Secretary on current and
future trends, challenges, and
opportunities presented by advances in
biological and life sciences,
biotechnology, and genetic engineering
with respect to threats posed by
naturally occurring infectious diseases
and chemical, biological, radiological,
and nuclear agents. At the request of the
Secretary, the Board shall review and
consider any information and findings
received from the working groups
established under 42 U.S.C. 247d–7f(b).
At the request of the Secretary, the
Board shall provide recommendations
and findings for expanded, intensified,
and coordinated biodefense research
and development activities. Additional
advisory duties concerning public
health emergency preparedness and
response may be assigned at the
discretion of the Secretary.
Structure: The Board shall consist of
13 voting members, including the
Chairperson; additionally, there may be
non-voting ex officio members.
Members and the Chairperson shall be
appointed by the Secretary from among
the Nation’s preeminent scientific,
public health and medical experts, as
follows: (a) Such Federal officials as the
Secretary determines are necessary to
support the functions of the Board, (b)
four individuals from the
pharmaceutical, biotechnology and
device industries, (c) four academicians,
and (d) five other members as
determined appropriate by the
Secretary, one of whom must be a
practicing health care professional and
one of whom must be from an
organization representing health care
consumers. Additional members for
category (d), above, will be selected
from among State and local
governments and public health
agencies, emergency medical responders
and organizations representing other
SUPPLEMENTARY INFORMATION:
E:\FR\FM\02JNN1.SGM
02JNN1
Federal Register / Vol. 75, No. 105 / Wednesday, June 2, 2010 / Notices
appropriate stakeholders. A member of
the Board described in (b), (c), and (d)
in the above paragraph shall serve for a
term of 3 years, except that the Secretary
may adjust the terms of the initial Board
appointees in order to provide for a
staggered term of appointment of all
members. Members who are not fulltime
or permanent part-time Federal
employees shall be appointed by the
Secretary as Special Government
Employees.
Dated: May 21, 2010.
Nicole Lurie,
Assistant Secretary for Preparedness and
Response, U.S. Department of Health and
Human Services.
[FR Doc. 2010–13177 Filed 6–1–10; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
sroberts on DSKD5P82C1PROD with NOTICES
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Cross-Site Evaluation of the
Garrett Lee Smith Memorial Suicide
Prevention and Early Intervention
Programs (OMB No. 0930–0286)—
Revision
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Mental Health
Services (CMHS) will continue to
conduct the cross-site evaluation of the
Garrett Lee Smith Memorial Youth
Suicide Prevention and Early
Intervention State/Tribal Programs and
the Garrett Lee Smith Memorial Youth
Suicide Prevention Campus Programs.
The data collected through the cross-site
evaluation addresses four stages of
program activity: (1) The context stage
includes a review of program plans,
such as grantee’s target population,
target region, service delivery
mechanisms, service delivery setting,
types of program activities to be funded
and evaluation activities; (2) the product
stage describes the prevention strategies
that are developed and utilized by
grantees; (3) the process stage assesses
progress on key activities and
VerDate Mar<15>2010
19:08 Jun 01, 2010
Jkt 220001
milestones related to implementation of
program plans; and (4) the impact stage
assesses the impact of the program on
early identification, referral for services
and service follow up of youth at risk.
Additionally, to obtain a
comprehensive understanding of the
integration of community-based
behavioral health services with services
provided by college or university
campuses, SAMHSA will conduct case
studies of four exemplary Campus
suicide prevention programs. Currently,
case studies of two campus grantees are
underway. The goal of the Campus Case
Studies is to understand how a public
health approach is successfully applied
as a model for campus suicide
prevention efforts, and will explore, in
a systematic manner: The suicide
prevention related infrastructures and
supports (e.g., clinical and non-clinical)
that exist on selected GLS-funded
campuses; the various student-level
factors that are related to suicide
prevention efforts (e.g., protective
factors, coping strategies, social norms,
and facilitators and barriers to student
access and receipt of behavioral
healthcare); campus interdepartmental
collaboration and the relationship
between various efforts to promote
student mental health and wellness; and
the extent to which the campus
infrastructures and supports promote
and address these factors.
To date, 86 State/Tribal grants and 93
Campus grants have participated in the
cross-site evaluation, since FY2007.
Currently, 48 State/Tribal grants and 38
Campus grants are participating in the
cross-site evaluation. Data will continue
to be collected from suicide prevention
program staff (e.g., project directors,
evaluators), key program stakeholders
(e.g., state/local officials, child-serving
agency directors, gatekeepers, mental
health providers, and campus
administrators), training participants,
college students, and campus faculty/
staff through FY2012.
Since the State/Tribal grantees differ
from the campus grantees in
programmatic approaches, specific data
collection activities also vary by type of
program. The following describes the
specific data collection activities and
data collection instruments to be used
across State/Tribal and Campus grantees
for the cross-site evaluation and the
specific data collection instruments to
be used by selected Campus grantees for
the Campus Case Studies. While most of
the data collection instruments
described below are revised versions of
instruments that have previously
received OMB approval (OMB No.
0930–0286 with Expiration Date: May
2010) and are currently in use, the
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
30833
Training Utilization and Preservation—
Survey (TUP–S) for State/Tribal
grantees and the Training Exit Survey
for Campus grantees (TES–C) are
proposed as new instruments. The
addition of these two new data
collection activities, the inclusion of the
Campus Case studies, and an overall
growth in number of grants for both the
State/Tribal and Campus programs has
increased the burden associated with
the cross-site evaluation. A summary
table of number of respondents and
respondent burden has also been
included.
Data Collection Activities for State/
Tribal Grantees
For State/Tribal grantees, the
Prevention Strategies Inventory State/
Tribal (PSI ST), Training Exit Survey
State/Tribal (TES ST), Referral Network
Survey (RNS) and Training Utilization
and Preservation—Interview (TUP–I)
described below are revised versions of
instruments that previously received
OMB approval (OMB No. 0930–0286
with Expiration Date: May 2010) and are
currently in use. The Training
Utilization and Preservation—Survey
(TUP–S) is proposed as a new data
collection instrument.
• Prevention Strategies InventoryState/Tribal (PSI ST)—Revised. The
Prevention Strategies Inventory will
collect information on the suicide
prevention strategies that grantees have
developed and utilized. Prevention
strategies include outreach and
awareness, gatekeeper training,
assessment and referral training for
mental health professionals and hotline
staff, lifeskills development programs,
screening programs, hotlines and
helplines, means restriction, policies
and protocols for intervention and
postvention, coalitions and
partnerships, and direct services and
traditional healing practices. Baseline
data will be collected from the State/
Tribal grantees at the beginning of their
grant cycle. Thereafter, they will
complete the PSI ST on a quarterly basis
over the duration of their grant period.
Baseline data will be collected on
information on the types of prevention
strategies grantees have developed and
utilized, and the follow-up data
collection asks the grantees to update
the information they have provided on
a quarterly basis over the period of the
grant. On average, 48 State/Tribal
grantees will fill out the PSI ST per year.
One respondent from each site will be
responsible for completing the survey.
The survey will take approximately 45
minutes; however, the number of
products, services and activities
implemented under each strategy will
E:\FR\FM\02JNN1.SGM
02JNN1
]]>Agencies
[Federal Register Volume 75, Number 105 (Wednesday, June 2, 2010)]
[Notices]
[Pages 30832-30833]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-13177]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Biodefense Science Board; Call for Nominees
AGENCY: Department of Health and Human Services, Office of the
Secretary.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of the Secretary is accepting resumes or curricula
vitae from qualified individuals who wish to be considered for
membership on the National Biodefense Science Board. Six members have
membership expiration dates of December 31, 2010. Nominees are being
accepted in the following categories: industry; academia, health care
consumers, and from State and local governments and public health
agencies, emergency responders and organizations representing other
appropriate stakeholders. Submit a resume or curriculum vitae to
nbsb@hhs.gov by June 30, 2010.
FOR FURTHER INFORMATION, CONTACT: CAPT Leigh A. Sawyer, D.V.M.,
M.P.H., Executive Director, National Biodefense Science Board, Office
of the Assistant Secretary for Preparedness and Response, U.S.
Department of Health and Human Services, 330 C Street, SW., Switzer
Building Room 5127, Washington, DC 20447; 202-205-3815; fax: 202-205-
8508; e-mail address: leigh.sawyer@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to section 319M of the Public
Health Service Act (42 U.S.C. 247d-7f) and section 222 of the Public
Health Service Act (42 U.S.C. 217a), the Department of Health and Human
Services established the National Biodefense Science Board. The Board
shall provide expert advice and guidance to the Secretary on
scientific, technical, and other matters of special interest to the
Department of Health and Human Services regarding current and future
chemical, biological, nuclear, and radiological agents, whether
naturally occurring, accidental, or deliberate. The Board may also
provide advice and guidance to the Secretary on other matters related
to public health emergency preparedness and response.
Discription of Duties: The Board shall advise the Secretary on
current and future trends, challenges, and opportunities presented by
advances in biological and life sciences, biotechnology, and genetic
engineering with respect to threats posed by naturally occurring
infectious diseases and chemical, biological, radiological, and nuclear
agents. At the request of the Secretary, the Board shall review and
consider any information and findings received from the working groups
established under 42 U.S.C. 247d-7f(b). At the request of the
Secretary, the Board shall provide recommendations and findings for
expanded, intensified, and coordinated biodefense research and
development activities. Additional advisory duties concerning public
health emergency preparedness and response may be assigned at the
discretion of the Secretary.
Structure: The Board shall consist of 13 voting members, including
the Chairperson; additionally, there may be non-voting ex officio
members. Members and the Chairperson shall be appointed by the
Secretary from among the Nation's preeminent scientific, public health
and medical experts, as follows: (a) Such Federal officials as the
Secretary determines are necessary to support the functions of the
Board, (b) four individuals from the pharmaceutical, biotechnology and
device industries, (c) four academicians, and (d) five other members as
determined appropriate by the Secretary, one of whom must be a
practicing health care professional and one of whom must be from an
organization representing health care consumers. Additional members for
category (d), above, will be selected from among State and local
governments and public health agencies, emergency medical responders
and organizations representing other
[[Page 30833]]
appropriate stakeholders. A member of the Board described in (b), (c),
and (d) in the above paragraph shall serve for a term of 3 years,
except that the Secretary may adjust the terms of the initial Board
appointees in order to provide for a staggered term of appointment of
all members. Members who are not fulltime or permanent part-time
Federal employees shall be appointed by the Secretary as Special
Government Employees.
Dated: May 21, 2010.
Nicole Lurie,
Assistant Secretary for Preparedness and Response, U.S. Department of
Health and Human Services.
[FR Doc. 2010-13177 Filed 6-1-10; 8:45 am]
BILLING CODE P
